Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith Sim

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2007
A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophagesRobert Van der Geize, Katherine Yam, Thomas Heuser, et al.
The Journal of Experimental Medicine|May 1, 2004
Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug targetSanjib Bhakta, Gurdyal S Besra, Anna M Upton, et al.
Plos One|August 14, 2013
A novel color change mechanism for breast cancer biomarker detection: naphthoquinones as specific ligands of human arylamine N-acetyltransferase 1Nicola Laurieri, James E Egleton, Amy Varney, et al.
Protein & Cell|January 5, 2011
Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tubercularsIsaac M Westwood, Sanjib Bhakta, Angela J Russell, et al.
Biomolecules|May 4, 2026
Fragment-Derived Nicotinic Acid Analogues Inhibit hCA III and Downregulate <i>CA3</i> Expression in HepG2 CellsAreej Abuhammad, Tamara Sabri, Nidaa A Ababneh, et al.
Plos One|January 4, 2013
Piperidinols that show anti-tubercular activity as inhibitors of arylamine N-acetyltransferase: an essential enzyme for mycobacterial survival inside macrophagesAreej Abuhammad, Elizabeth Fullam, Edward D Lowe, et al.
British Journal of Pharmacology|April 6, 2017
Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approachAli Ryan, Elena Polycarpou, Nathan A Lack, et al.
Bioorganic & Medicinal Chemistry|April 25, 2014
Structure-activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1James E Egleton, Cyrille C Thinnes, Peter T Seden, et al.
Molecular Cancer Research : MCR|October 1, 2003
Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitroPaul J Adam, Joanne Berry, Julie A Loader, et al.
The FEBS Journal|September 30, 2022
Fusarium verticillioides NAT1 (FDB2) N-malonyltransferase is structurally, functionally and phylogenetically distinct from its N-acetyltransferase (NAT) homologuesEleni-Pavlina Karagianni, Evanthia Kontomina, Edward D Lowe, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2007
A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophagesRobert Van der Geize, Katherine Yam, Thomas Heuser, et al.
The Journal of Experimental Medicine|May 1, 2004
Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug targetSanjib Bhakta, Gurdyal S Besra, Anna M Upton, et al.
Plos One|August 14, 2013
A novel color change mechanism for breast cancer biomarker detection: naphthoquinones as specific ligands of human arylamine N-acetyltransferase 1Nicola Laurieri, James E Egleton, Amy Varney, et al.
Protein & Cell|January 5, 2011
Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tubercularsIsaac M Westwood, Sanjib Bhakta, Angela J Russell, et al.
Biomolecules|May 4, 2026
Fragment-Derived Nicotinic Acid Analogues Inhibit hCA III and Downregulate <i>CA3</i> Expression in HepG2 CellsAreej Abuhammad, Tamara Sabri, Nidaa A Ababneh, et al.
Plos One|January 4, 2013
Piperidinols that show anti-tubercular activity as inhibitors of arylamine N-acetyltransferase: an essential enzyme for mycobacterial survival inside macrophagesAreej Abuhammad, Elizabeth Fullam, Edward D Lowe, et al.
British Journal of Pharmacology|April 6, 2017
Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approachAli Ryan, Elena Polycarpou, Nathan A Lack, et al.
Bioorganic & Medicinal Chemistry|April 25, 2014
Structure-activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1James E Egleton, Cyrille C Thinnes, Peter T Seden, et al.
Molecular Cancer Research : MCR|October 1, 2003
Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitroPaul J Adam, Joanne Berry, Julie A Loader, et al.
The FEBS Journal|September 30, 2022
Fusarium verticillioides NAT1 (FDB2) N-malonyltransferase is structurally, functionally and phylogenetically distinct from its N-acetyltransferase (NAT) homologuesEleni-Pavlina Karagianni, Evanthia Kontomina, Edward D Lowe, et al.
Pageof 10